| Synonyms: | |
| Status: | Approved (1955) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | P01BA02 |
| UNII: | 4QWG6N8QKH |
| InChI Key | XXSMGPRMXLTPCZ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H26ClN3O |
| Molecular Weight | 335.88 |
| AlogP | 3.78 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 48.39 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 23.0 |
| Primary Target | |
|---|---|
| TLR7 | |
| TLR9 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Toll-like and Il-1 receptors
|
- | 800-8600 | - | - | - | |
|
Unclassified protein
|
- | - | - | 92300 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteoarthritis | 3 | D010003 | ClinicalTrials |
| Coronavirus Infections | 3 | D018352 | ClinicalTrials |
| Arthritis, Rheumatoid | 3 | D001172 | ClinicalTrials |
| Antiphospholipid Syndrome | 3 | D016736 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 3 | D008180 | ClinicalTrials |
| Pregnancy | 3 | D011247 | ClinicalTrials |
| Lupus Erythematosus, Cutaneous | 3 | D008178 | ClinicalTrials |
| Graft vs Host Disease | 3 | D006086 | ClinicalTrials |
| Sjogren's Syndrome | 3 | D012859 | ClinicalTrials |
| Pneumonia | 3 | D011014 | ClinicalTrials |
| Sarcoidosis, Pulmonary | 3 | D017565 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Respiratory Insufficiency | 3 | D012131 | ClinicalTrials |
| Abortion, Habitual | 3 | D000026 | ClinicalTrials |
| Giant Cell Arteritis | 3 | D013700 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Thrombocytopenia | 3 | D013921 | ClinicalTrials |
| Infections | 3 | D007239 | ClinicalTrials |
| Respiratory Distress Syndrome | 3 | D012128 | ClinicalTrials |
| Respiratory Distress Syndrome | 3 | D012128 | ClinicalTrials |
| Pneumonia, Pneumocystis | 3 | D011020 | ClinicalTrials |
| Pneumonia, Viral | 3 | D011024 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | D015451 | ClinicalTrials |
| Carcinoma, Hepatocellular | 2 | D006528 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Crohn Disease | 2 | D003424 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Leukemia | 2 | D007938 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
| HIV Infections | 2 | D015658 | ClinicalTrials |
| Diabetes Mellitus, Type 1 | 2 | D003922 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Multiple Sclerosis, Chronic Progressive | 2 | D020528 | ClinicalTrials |
| Osteoarthritis, Knee | 2 | D020370 | ClinicalTrials |
| Lichen Planus | 2 | D008010 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Porphyria Cutanea Tarda | 2 | D017119 | ClinicalTrials |
| Zellweger Syndrome | 2 | D015211 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Cholangiocarcinoma | 2 | D018281 | ClinicalTrials |
| Adenocarcinoma | 1 | D000230 | ClinicalTrials |
| Hidradenitis Suppurativa | 1 | D017497 | ClinicalTrials |
| Hepatitis C, Chronic | 1 | D019698 | ClinicalTrials |
| Hepatitis C | 1 | D006526 | ClinicalTrials |
| Insulin Resistance | 1 | D007333 | ClinicalTrials |
| Osteosarcoma | 1 | D012516 | ClinicalTrials |
| Lymphangioleiomyomatosis | 1 | D018192 | ClinicalTrials |
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Central Nervous System Neoplasms | 1 | D016543 | ClinicalTrials |
| Carcinoma, Renal Cell | 1 | D002292 | ClinicalTrials |
| Glioma | 1 | D005910 | ClinicalTrials |
| Ovarian Neoplasms | 1 | D010051 | ClinicalTrials |
| Retinitis Pigmentosa | 1 | D012174 | ClinicalTrials |
| Lung Neoplasms | 1 | D008175 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
| Carcinoma, Renal Cell | 1 | D002292 | ClinicalTrials |
| Cystic Fibrosis | 1 | D003550 | ClinicalTrials |
| Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
| Prostatic Neoplasms | 0 | D011471 | ClinicalTrials |
| Lung Diseases, Interstitial | 0 | D017563 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 118-42-3 |
| ChEBI | 5801 |
| ChEMBL | CHEMBL1535 |
| DrugBank | DB01611 |
| DrugCentral | 1395 |
| EPA CompTox | DTXSID8023135 |
| FDA SRS | 4QWG6N8QKH |
| Human Metabolome Database | HMDB0015549 |
| Guide to Pharmacology | 7198 |
| KEGG | C07043 |
| PharmGKB | PA164777036 |
| PubChem | 3652 |
| SureChEMBL | SCHEMBL8170 |